Biological Institute, Weizmann Institute sign COVID-19 cooperation

News

FacebookGoogleLinkedInTwitter

05 May, 2020   News

---
This article was originally published on April 19, 2020 on the digital media israelnationalnews.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes.
---

The Biological Institute and the Weizmann Institute of Science will join hands in advancing research designed to develop ways to combat the coronavirus. The Memorandum of Understanding between the two institutes, in this regard, has been signed in recent days.

The two neighboring institutes are characterized by unique excellence, each in their own field, and collaboration between them can result in significant synergy and acceleration (a multiplier) in the process that scientists hope will lead to a medical response to the virus.

Biological Institute Director Prof. Shmuel Shapiro and Weizmann Institute of Science and Technology Applications Vice President Prof. Irit Sagi say signing the Memorandum of Understanding is a milestone in broader joint activity between the two institutes.

---
Keep up to date on Innoget's initiative to beat Covid-19 by following the dedicated channel where new innovation needs, novel technologies, news, and events are posted daily.

Other News

NIH researchers investigate virulence of SARS-CoV-2 virus

  • 25 June, 2020

--- This article was originally published by Samantha Black, PhD, The Science Advisory Board staff writer on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- What makes the SARS-CoV-2 virus so virulent? Researchers from the U.S. National Institutes of Health (NIH) analyzed the genomics of the virus -- and compar...

Read more about this

Sexton, BioSpherix collaborate to support cell & gene therapy needs

  • 25 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Sexton Biotechnologies is partnering with BioSpherix Medical on the final steps of downstream bioprocessing, fill-finish. Sexton's off-the-shelf fill system, the Sexton Biot...

Read more about this

Ideaya and GSK partner on synthetic lethality programs

  • 25 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Ideaya Biosciences and GlaxoSmithKline (GSK) have formed a strategic partnership in the emerging oncology field of synthetic lethality. Synthetic lethality occurs when the combi...

Read more about this


Find More News